Skip to content

Methotrexate

Generic Medicine With 19 Brands Available In Bangladesh. Read What It Is For And How It Is Taken, Then Compare The Brands By Strength, Maker And Price.

Generic Guide

About Methotrexate

What This Generic Is For, How It Is Taken, And What To Watch For.

Indications

Vasculitis Neoplastic Diseases: Methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. Methotrexate is used in maintenance therapy in combination with other chemotherapeutic agents. Methotrexate is used alone or ... Read more Neoplastic Diseases: Methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. Methotrexate is used in maintenance therapy in combination with other chemotherapeutic agents. Methotrexate is used alone or in combination with other anticancer agents in the treatment of breast  cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous T cell lymphoma), and lung cancer, particularly squamous cell and small cell types. Methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-Hodgkin's lymphomas. Psoriasis: Methotrexate is indicated in the symptomatic control of severe, recalcitrant, disabling psoriasis that is not adequately responsive to other forms of therapy, but only when the diagnosis has been established, as by biopsy and/or after dermatologic consultation. It is important to ensure that a psoriasis “flare” is not due to an undiagnosed concomitant disease affecting immune responses. Rheumatoid Arthritis Including Polyarticular-Course Juvenile Rheumatoid Arthritis: Methotrexate is indicated in the management of selected adults with severe, active, rheumatoid arthritis (ACR criteria), or children with active polyarticular course juvenile rheumatoid arthritis, who have had an insufficient therapeutic response to, or are intolerant of, an adequate trial of first-line therapy including full dose non-steroidal anti-inflammatory agents (NSAIDs). Aspirin, NSAIDs, and/or low dose steroids may be continued, although the possibility of increased toxicity with concomitant use of NSAIDs including salicylates has not been fully explored. Steroids may be reduced gradually in patients who respond to methotrexate. Combined use of methotrexate with gold, penicillamine, hydroxychloroquine, sulfasalazine, or cytotoxic agents, has not been studied and may increase the incidence of adverse effects. Rest and physiotherapy as indicated should be continued.

Dosage And Administration

Oral- Choriocarcinoma: 15-30 mg daily for 5 days, repeat after an interval of ≥1 wk for 3-5 courses. Acute lymphoblastic leukaemia: Maintenance: 15 mg/m2 once or twice wkly, with other agents. Burkitt's lymphoma: 10-25 mg daily for 4-8 days, repeated after 7-10 days. Psoriasis: 10-25 mg wkly as a single dose, adjust subsequent doses based on response. Rheumatoid arthritis: 7.5 mg once wkly, adjust by response. Not more than 20 mg/wk. Mycosis fungoides: 2.5-10 mg daily to induce remission. Crohn's disease: 12.5-22.5 mg once wkly for up to 1 yr. Parenteral- Psoriasis: 10-25 mg wkly as a single dose. Adjust subsequent doses based on response. May be given via IV/IM admin. Intramuscular- Choriocarcinoma: 15-30 mg daily for 5 days. Repeat after at least 1 wk for 3-5 courses. Alternatively, 0.25-1 mg/kg (max: 60 mg) every 48 hr for 4 doses followed by folinic acid rescue, repeat at intervals of 7 days for 4 or more courses. Mycosis fungoides: 50 mg wkly as a single dose or 2 divided doses. Acute lymphoblastic leukaemia: Maintenance: 15 mg/m2 once or twice wkly, with other agents. Crohn's disease: 25 mg once wkly for 16 wk. Maintenance: 15 mg wkly. Intrathecal- Meningeal leukaemia: 12 mg/m2 (max 15 mg) once wkly for 2-3 wk, then once mthly. Alternatively, 200-500 mcg/kg every 2-5 day until CSF cell count is normalised. Intravenous- Osteosarcoma: Initial recommended dose: 12 g/m2 as a 4-hr infusion, followed by folinic acid, as part of combined therapy. May increase dose to 15 g/m2 in subsequent treatments if initial dosage is insufficient to achieve peak serum methotrexate levels of 454 mcg/mL at the end of the infusion. Methotrexate infusion is administered on postoperative wk 4, 5, 6, 7, 11, 12, 15, 16, 29, 30, 44 and 45; in combination with other chemotherapy agents. Folinic acid can be given orally, IM or IV inj starting 24 hr after the beginning of the methotrexate infusion. Give via parenteral routes If patient experiences GI toxicity (e.g., nausea, vomiting). Usual dosage of folinic acid: 15 mg every 6 hr for a total of 60 hr or a total of 10 doses. Breast cancer: 10-60 mg/m2 often with cyclophosphamide and fluorouracil. Advanced lymphosarcoma: Up to 30 mg/kg, followed by folinic acid rescue. Acute lymphoblastic leukaemia: Maintenance: 2.5 mg/kg every 14 days.

Side Effects

Ulceration of the mouth and GI disturbances (e.g. stomatitis and diarrhoea), bone marrow depression, hepatotoxicity, renal failure, skin reactions, alopecia, ocular irritation, arachnoiditis in intrathecal use, megaloblastic anaemia, osteoporosis, precipitation of diabetes, arthralgias, necrosis of soft tissue and bone, anaphylaxis, impaired fertility.

Precautions And Warnings

Hepatic or renal impairment, bone marrow depression, elderly, neonates. Ulcerative disorders of the GI tract. Monitor haematological, renal and hepatic function, and GI toxicity regularly.

Pregnancy And Lactation

Pregnancy category X. Studies in animals or human beings have demonstrated fetal abnormalities or there is evidence of fetal risk based on human experience or both, and the risk of the use of the drug in pregnant women clearly outweighs any possible benefit. The drug is contraindicated in women who are or may become pregnant.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Clinical Details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Available Brand Names: 19

Sorted By
Tablet

Meth 10 mg

Generic: Methotrexate

12.00Taka / Unit

View Medicine
Tablet

Meth 2.5 mg

Generic: Methotrexate

4.00Taka / Unit

View Medicine
Tablet

Methotrax 2.5 mg

Generic: Methotrexate

5.00Taka / Unit

View Medicine
Tablet

Methotrax 15 mg

Generic: Methotrexate

20.00Taka / Unit

View Medicine
Tablet

Methotrax 10 mg

Generic: Methotrexate

15.00Taka / Unit

View Medicine
Tablet

Methox 10 mg

Generic: Methotrexate

15.06Taka / Unit

View Medicine
Tablet

Methox 2.5 mg

Generic: Methotrexate

5.52Taka / Unit

View Medicine
Tablet

Metorax 10 mg

Generic: Methotrexate

15.00Taka / Unit

View Medicine
Tablet

Mtrex 2.5 mg

Generic: Methotrexate

5.00Taka / Unit

View Medicine
Injection

Mtrex 50 mg/2 ml

Generic: Methotrexate

110.00Taka / 50 mg vial

View Medicine
Tablet

Mtrex 10 mg

Generic: Methotrexate

15.00Taka / Unit

View Medicine
Injection

MTX 50 mg/2 ml

Generic: Methotrexate

130.00Taka / 50 mg vial

View Medicine
Tablet

MTX 2.5 mg

Generic: Methotrexate

5.40Taka / Unit

View Medicine
Tablet

Trexall 2.5 mg

Generic: Methotrexate

5.00Taka / Unit

View Medicine
Tablet

Trexall 10 mg

Generic: Methotrexate

15.00Taka / Unit

View Medicine
Injection

Trexall 50 mg/2 ml

Generic: Methotrexate

150.00Taka / 50 mg vial

View Medicine
Injection

Trexonate 50 mg/2 ml

Generic: Methotrexate

130.00Taka / 50 mg vial

View Medicine
Tablet

Trexonate 10 mg

Generic: Methotrexate

15.00Taka / Unit

View Medicine
Tablet

Trexonate 2.5 mg

Generic: Methotrexate

5.00Taka / Unit

View Medicine

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250